User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 19:46, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Ontology Term : 'liver disease pathway' added !)
- 19:45, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Ontology Term : 'disease pathway' added !)
- 19:36, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add literature reference)
- 19:32, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Identifier remaining nodes)
- 19:29, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add Wikidata IDs as identifiers for disease nodes)
- 19:26, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add Wikidata as database name for disease nodes)
- 19:17, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Use PubChem compound identifier for oxoloacetate, as it is undefined in ChEBI)
- 19:16, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add ChEBI IDs as database identifiers for metabolite nodes, where defined)
- 19:07, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add ChEBI as database name for metabolite nodes)
- 19:02, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add Ensembl IDs as database identifiers for genes)
- 18:41, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add Ensembl as database name for gene nodes)
- 17:07, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Economize layout)
- 17:05, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Label cell type: hepatocyte)
- 17:04, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Economize layout)
- 17:01, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add more interactions, connect groups, emphasize main source and destination nodes)
- 15:52, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add interactions, cell membrane)
- 15:20, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (Add more nodes, arrange)
- 14:50, 7 December 2024 N Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome (New pathway)
- 14:00, 26 November 2024 Homo sapiens:Complement and coagulation cascades (Standardize case)
- 13:59, 26 November 2024 Homo sapiens:Complement and coagulation cascades (Economize layout)
- 13:46, 26 November 2024 Homo sapiens:Complement and coagulation cascades (Increase font size)
- 02:13, 21 November 2024 Homo sapiens:Oncostatin M signaling (Fix typo)
- 02:12, 21 November 2024 Homo sapiens:Oncostatin M signaling (Ontology Term : 'lung carcinoma' added !)
- 02:11, 21 November 2024 Homo sapiens:Oncostatin M signaling (Ontology Term : 'osteosarcoma' added !)
- 02:10, 21 November 2024 Homo sapiens:Oncostatin M signaling (Ontology Term : 'aortic smooth muscle cell' added !)
- 02:10, 21 November 2024 Homo sapiens:Oncostatin M signaling (Ontology Term : 'astrocyte' added !)
- 02:09, 21 November 2024 Homo sapiens:Oncostatin M signaling (Ontology Term : 'osteoblast' added !)
- 02:09, 21 November 2024 Homo sapiens:Oncostatin M signaling (Ontology Term : 'cortical cell of adrenal gland' added !)
- 02:08, 21 November 2024 Homo sapiens:Oncostatin M signaling (Ontology Term : 'mammary gland epithelial cell' added !)
- 02:08, 21 November 2024 Homo sapiens:Oncostatin M signaling (Ontology Term : 'luminal epithelial cell of mammary gland' added !)
- 01:56, 21 November 2024 Homo sapiens:Oncostatin M signaling (Fix group position)
- 00:25, 21 November 2024 Homo sapiens:Oncostatin M signaling (Remove obsolete pathway metadata)
- 00:24, 21 November 2024 Homo sapiens:Oncostatin M signaling (Add cell membrane, economize layout)
- 00:19, 21 November 2024 Homo sapiens:Oncostatin M signaling (Standardize nucleus representation)
- 23:01, 20 November 2024 Homo sapiens:Oncostatin M signaling (Modified description)
- 22:57, 20 November 2024 Homo sapiens:Oncostatin M signaling (Refine legend)
- 22:55, 20 November 2024 Homo sapiens:Oncostatin M signaling (Economize layout)
- 12:40, 20 November 2024 Caenorhabditis elegans:Regulation of immune response in the intestine (Economize layout) (top)
- 12:24, 20 November 2024 Mus musculus:Dopaminergic neurogenesis (Align headers) (top)
- 12:23, 20 November 2024 Mus musculus:Dopaminergic neurogenesis (Use gene symbols; fix truncation; standardize spelling, node color)
- 04:21, 20 November 2024 Homo sapiens:Sterol regulatory element-binding proteins (SREBP) signaling (Increase font size)
- 04:15, 20 November 2024 Homo sapiens:Sterol regulatory element-binding proteins (SREBP) signaling (Refine legend)
- 04:10, 20 November 2024 Homo sapiens:Sterol regulatory element-binding proteins (SREBP) signaling (Economize layout)
- 03:59, 20 November 2024 Homo sapiens:Mammary gland development: involution - stage 4 of 4 (Simplify interaction modeling)
- 03:57, 20 November 2024 Homo sapiens:Mammary gland development: puberty - stage 2 of 4 (Simplify interaction modeling)
- 03:55, 20 November 2024 Homo sapiens:Mammary gland development: embryonic development - stage 1 of 4 (Simplify interaction modeling)
- 03:38, 20 November 2024 Homo sapiens:B cell receptor signaling (Clear cache)
- 02:00, 20 November 2024 Homo sapiens:B cell receptor signaling (Economize layout)
- 01:52, 20 November 2024 Homo sapiens:B cell receptor signaling (Clear cache to tailor board dimensions)
- 01:50, 20 November 2024 Homo sapiens:B cell receptor signaling (Economize layout, standardize nucleus representation)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
